APA (7th ed.) Citation

Grimaldi-Bensouda, L., Zureik, M., Molimard, M., Aubier, M., & Abenhaim, L. (2011). PRS3 RELATIVE EFFECTIVENESS STUDY OF OMALIZUMAB: THE USE OF BEFORE-AFTER COHORT METHODOLOGY FOR COVERAGE WITH EVIDENCE DEVELOPMENT. Value in Health, A137. https://doi.org/10.1016/j.jval.2011.02.764

Chicago Style (17th ed.) Citation

Grimaldi-Bensouda, L., M. Zureik, M. Molimard, M. Aubier, and L. Abenhaim. "PRS3 RELATIVE EFFECTIVENESS STUDY OF OMALIZUMAB: THE USE OF BEFORE-AFTER COHORT METHODOLOGY FOR COVERAGE WITH EVIDENCE DEVELOPMENT." Value in Health 2011: A137. https://doi.org/10.1016/j.jval.2011.02.764.

MLA (9th ed.) Citation

Grimaldi-Bensouda, L., et al. "PRS3 RELATIVE EFFECTIVENESS STUDY OF OMALIZUMAB: THE USE OF BEFORE-AFTER COHORT METHODOLOGY FOR COVERAGE WITH EVIDENCE DEVELOPMENT." Value in Health, 2011, p. A137, https://doi.org/10.1016/j.jval.2011.02.764.